PROFFERED PAPERS
Tuesday, March 1   —  8:00 AM   —  Convention Center Bridge Hall


Click on the numbers in parentheses to display abstracts.



Section B - HEMATOPATHOLOGY
Chaired by: Ahmet Dogan and Jerald Z. Gong



8:00 Campylobacter jejuni Infection in Intestinal Lymphoma: A Strong Association with Immunoproliferative Small Intestinal Disease (1058)
A Dogan, L Baginsky, TC Diss, H Ye, MQ Du, PG Isaacson - University College London, London, United Kingdom; University of Cambridge, Cambridge, United Kingdom
8:15 BCL6 Involved Chromosomal Translocation in MALT Lymphoma of Various Sites (1194)
H Ye, AG Nicholson, A Dogan, MQ Du - University of Cambridge, Cambridge, United Kingdom; Royal Brompton Hospital, London, United Kingdom; University College London, London, United Kingdom
8:30 Immunoglobulin VH Gene Analysis Suggests Primary Cutaneous Marginal Zone B-Cell Lymphomas May Recognize Similar Antigens (1036)
DW Bahler, BK Kim, A Gao, SH Swerdlow - University of Utah, Salt Lake City, UT; University of Pittsburgh, Pittsburgh, PA
8:45 Comparative Genomic Hybridization in Monomorphous Post-Transplant Lymphoproliferative Disorders (1126)
M Nelson, V Neppalli, Z VanDyke, B Dave, J Coad, W Sanger, TC Greiner - University of Nebraska Medical Center, Omaha, NE; University of Nebraska Medical Center, Omaha, NE; University of West Virginia, Morgantown, WV
9:00 IgD Positive L&H Cells Identify a Unique Subset of Nodular Lymphocyte Predominant Hodgkin Lymphoma (1144)
S Prakash, T Fountaine, M Raffeld, ES Jaffe, S Pittaluga - National Cancer Institute, Bethesda, MD
9:15 Cytogenetic Abnormalities in Reactive Lymphoid Hyperplasia; Morphologic and Clinical Correlates (1167)
X-L Sun, VV Murty, B Alobeid, G Bhagat - Columbia University, New York, NY
9:30 RECESS, EXHIBITS, POSTER SESSION III
11:00 T-Cell Receptor Signaling and Growth Pathways in T-Cell Tumors (1022)
JH Admirand, M Herling, K Patel, GZ Rassidakis, MP Oyarzo, LJ Medeiros, D Jones - The University of Texas M.D. Anderson Cancer Center, Houston, TX
11:15 Peripheral T-Cell Lymphoma (PTCL): A Clinicopathologic Analysis with Comparison to Diffuse Large B-Cell Lymphoma (DLBCL) (1186)
DD Weisenburger, P Aoun, TC Greiner, WC Chan, LM Smith, RG Bociek, PJ Bierman, JM Vose, JO Armitage - University of Nebraska Medical Center, Omaha, NE
11:30 Targeting Oncogenic ALK by Lentiviral Small Interfering RNA Induces Growth Arrest and Apoptosis of Human Anaplastic Large Cell Lymphoma Cells (1141)
R Piva, A Manazza, R Taulli, C Ponzetto, W Simmons, R Chiarle, G Inghirami - University of Torino, Turin, Italy; New York University School of Medicine, New York, NY
11:45 Inactivation of the Extrinsic Apoptotic Pathway in ALK+ Anaplastic Large Cell Lymphoma (ALCL) (1133)
MP Oyarzo, LJ Medeiros, C Atwell, S Wang, E Drakos, GZ Rassidakis - The University of Texas MD Anderson Cancer Center, Houston, TX